 BRIDGEWATER, N.J., Feb. 19, 2021 PRNewswire -- Insmed Incorporated Nasdaq:INSM, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced topline results from the Phase 1 study of treprostinil palmitil inhalation... 